GlassScriptPhysician profile
John P Mcmurry
NPI 1396708764
$530.16
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.53 · 2020: $87.41 · 2021: $219 · 2022: $120 · 2023: $78.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $103.54 | 2019-2021 | |
| Abbvie INC. | $78.28 | 2020-2022 | |
| Pfizer INC. | $52.46 | 2021 | |
| Myovant Sciences INC. | $50.99 | 2021-2022 | |
| Corcept Therapeutics | $38.70 | 2023 | Korlym |
| Olympus America INC. | $29.38 | 2021 | |
| Medtronic USA, INC. | $26.95 | 2020 | |
| Avanos Medical | $25.32 | 2023 | On-Q* Pump and Accessories |
| Becton, Dickinson and Company | $24.89 | 2022 | |
| Abbott Laboratories | $18.92 | 2022 | |
| Daiichi Sankyo INC. | $14.49 | 2019 | |
| Astellas Pharma US INC | $14.21 | 2023 | Veozah |
| Baxter Healthcare | $13.49 | 2021 | |
| Esperion Therapeutics, INC. | $13.36 | 2021 | |
| Axonics, INC. | $13.00 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $12.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcmurry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.